The international Unity study for antivirals against mpox is a blueprint for future epidemics
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Nature medicine - 29(2023), 8 vom: 30. Aug., Seite 1894-1895 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Telford, Erica [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 17.08.2023 Date Revised 13.12.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41591-023-02393-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358929105 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358929105 | ||
| 003 | DE-627 | ||
| 005 | 20231227131347.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41591-023-02393-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM358929105 | ||
| 035 | |a (NLM)37391664 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Telford, Erica |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The international Unity study for antivirals against mpox is a blueprint for future epidemics |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.08.2023 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Grinsztejn, Beatriz |e verfasserin |4 aut | |
| 700 | 1 | |a Olsen, Inge Christoffer |e verfasserin |4 aut | |
| 700 | 1 | |a Pulik, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Mentré, France |e verfasserin |4 aut | |
| 700 | 1 | |a Haviari, Skerdi |e verfasserin |4 aut | |
| 700 | 1 | |a Hentzien, Maxime |e verfasserin |4 aut | |
| 700 | 1 | |a Ségéral, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Ekkelenkamp, Miquel B |e verfasserin |4 aut | |
| 700 | 1 | |a Ogoina, Dimie |e verfasserin |4 aut | |
| 700 | 1 | |a Strub-Wourgaft, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Diallo, Alpha |e verfasserin |4 aut | |
| 700 | 1 | |a Yazdanpanah, Yazdan |e verfasserin |4 aut | |
| 700 | 1 | |a Calmy, Alexandra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature medicine |d 1995 |g 29(2023), 8 vom: 30. Aug., Seite 1894-1895 |w (DE-627)NLM074659804 |x 1546-170X |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:8 |g day:30 |g month:08 |g pages:1894-1895 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41591-023-02393-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 8 |b 30 |c 08 |h 1894-1895 | ||